MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Enveric Biosciences, Inc. - Common Stock (NQ:ENVB)

5.840 +0.020 (+0.34%)
Streaming Delayed Price Updated: 9:57 AM EST, Dec 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,445
Open 5.610
Bid (Size) 5.600 (400)
Ask (Size) 5.840 (100)
Prev. Close 5.820
Today's Range 5.610 - 5.840
52wk Range 4.880 - 1,444.50
Shares Outstanding 596,978
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Enveric Biosciences Receives Fourth Notice of Allowance for EVM401 Series of Drug Candidates
From Enveric Biosciences
Via Business Wire
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
 
Via Benzinga

Performance

YTD
-99.4%
-99.4%
1 Month
-17.5%
-17.5%
3 Month
-55.4%
-55.4%
6 Month
-61.7%
-61.7%
1 Year
-99.3%
-99.3%

More News

Read More
News headline image
Enveric Biosciences Reports Third Quarter 2025 Financial and Corporate Results
From Enveric Biosciences
Via Business Wire
News headline image
Which stocks are moving on Monday? ↗
Via Chartmill
News headline image
Enveric Biosciences Announces Reverse Stock Split
From Enveric Biosciences
Via Business Wire
News headline image
Enveric Biosciences Further Enhances Intellectual Property Estate with New U.S. Patent Issuance
From Enveric Biosciences
Via Business Wire
News headline image
Enveric Biosciences Hires IP Powerhouse to Defend Its U.S. Patent with Claims Relevant to Bretisilocin, Recently Acquired by AbbVie in $1.2 Billion Deal
From Enveric Biosciences
Via Business Wire
News headline image
Enveric Biosciences to Explore Digital Asset Treasury Opportunities
From Enveric Biosciences
Via Business Wire
News headline image
These stocks are gapping in today's session ↗
Via Chartmill
News headline image
These stocks that are showing activity before the opening bell on Friday. ↗
Via Chartmill
News headline image
Enveric Biosciences Successfully Completes Key Manufacturing Milestones in Support of Planned IND and Clinical Trials
From Enveric Biosciences
Via Business Wire
News headline image
Stay updated with the stocks that are on the move in today's pre-market session. ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
Via Benzinga
News headline image
Stay updated with the stocks that are on the move in today's after-hours session. ↗
Via Chartmill
News headline image
Enveric Biosciences Announces Closing of Exercise of Warrants for $2.2 Million Gross Proceeds
From Enveric Biosciences, Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
Via Benzinga
News headline image
Which stocks are experiencing notable movement on Wednesday? ↗
Via Chartmill
News headline image
Wednesday's session: gap up and gap down stocks ↗
Via Chartmill
News headline image
Enveric Biosciences Announces Exercise of Warrants for $2.2 Million Gross Proceeds
From Enveric Biosciences, Inc.
Via Business Wire
News headline image
Enveric Biosciences Announces Publication of Two Peer-Reviewed Articles Highlighting Novel Bioproduction Methods for Neuropsychiatric Drug Discovery
From Enveric Biosciences
Via Business Wire
News headline image
Enveric Biosciences Receives FDA Response and Streamlines Plans for EB-003 IND Submission
From Enveric Biosciences
Via Business Wire
News headline image
Enveric Biosciences to Present at H.C. Wainwright 27th Annual Global Investment Conference
From Enveric Biosciences
Via Business Wire
News headline image
Enveric Biosciences Relocates Corporate Headquarters to Cambridge, MA
From Enveric Biosciences
Via Business Wire
News headline image
Enveric Biosciences Successfully Completes Pre-IND Dose Range Finding Studies for Lead Candidate EB-003, Targeting Neuropsychiatric Indications
From Enveric Biosciences, Inc.
Via Business Wire
News headline image
Enveric Biosciences Reports Second Quarter 2025 Financial and Corporate Results
From Enveric Biosciences
Via Business Wire

Frequently Asked Questions

Is Enveric Biosciences, Inc. - Common Stock publicly traded?
Yes, Enveric Biosciences, Inc. - Common Stock is publicly traded.
What exchange does Enveric Biosciences, Inc. - Common Stock trade on?
Enveric Biosciences, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Enveric Biosciences, Inc. - Common Stock?
The ticker symbol for Enveric Biosciences, Inc. - Common Stock is ENVB on the Nasdaq Stock Market
What is the current price of Enveric Biosciences, Inc. - Common Stock?
The current price of Enveric Biosciences, Inc. - Common Stock is 5.840
When was Enveric Biosciences, Inc. - Common Stock last traded?
The last trade of Enveric Biosciences, Inc. - Common Stock was at 12/03/25 09:57 AM ET
What is the market capitalization of Enveric Biosciences, Inc. - Common Stock?
The market capitalization of Enveric Biosciences, Inc. - Common Stock is 3.49M
How many shares of Enveric Biosciences, Inc. - Common Stock are outstanding?
Enveric Biosciences, Inc. - Common Stock has 3M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story